Louis P Garrison
Louis P Garrison
Professor Emeritus, University of Washington
Verified email at
Cited by
Cited by
Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers
JJ Carlson, SD Sullivan, LP Garrison, PJ Neumann, DL Veenstra
Health policy 96 (3), 179-190, 2010
Performance-based risk-sharing arrangements—good practices for design, implementation, and evaluation: report of the ISPOR good practices for performance-based risk-sharing …
LP Garrison Jr, A Towse, A Briggs, G de Pouvourville, J Grueger, PE Mohr, ...
Value in health 16 (5), 703-719, 2013
Donor availability as the primary determinant of the future of heart transplantation
RW Evans, DL Manninen, LP Garrison, AM Maier
Jama 255 (14), 1892-1898, 1986
Challenges in the development and reimbursement of personalized medicine—payer and manufacturer perspectives and implications for health economics and outcomes research: a …
E Faulkner, L Annemans, L Garrison, M Helfand, AP Holtorf, J Hornberger, ...
Value in Health 15 (8), 1162-1171, 2012
Pharmacoeconomic analysis of adjuvant oral capecitabine vs intravenous 5-FU/LV in Dukes' C colon cancer: the X-ACT trial
J Cassidy, JY Douillard, C Twelves, JJ McKendrick, W Scheithauer, ...
British journal of cancer 94 (8), 1122-1129, 2006
Can’t get no satisfaction? Will pay for performance help? Toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products
A Towse, LP Garrison
Pharmacoeconomics 28, 93-102, 2010
Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force Report—Part I
JW Hay, J Smeeding, NV Carroll, M Drummond, LP Garrison, EC Mansley, ...
Value in Health 13 (1), 3-7, 2010
Performance-based risk-sharing arrangements: an updated international review
JJ Carlson, S Chen, LP Garrison
Pharmacoeconomics 35, 1063-1072, 2017
Global eradication of measles: an epidemiologic and economic evaluation
A Levin, C Burgess, LP Garrison, C Bauch, J Babigumira, E Simons, ...
The Journal of infectious diseases 204 (suppl_1), S98-S106, 2011
Interspecialty variation in office-based care
HP Greenwald, ML Peterson, LP Garrison, LG Hart, IS Moscovice, TL Hall, ...
Medical care 22 (1), 14-29, 1984
A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice
DL Veenstra, JA Roth, LP Garrison Jr, SD Ramsey, W Burke
Genetics in Medicine 12 (11), 686-693, 2010
Value-based pricing for emerging gene therapies: the economic case for a higher cost-effectiveness threshold
LP Garrison, T Jackson, D Paul, M Kenston
Journal of managed care & specialty pharmacy 25 (7), 793-799, 2019
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations
SM Smith, RH Dworkin, DC Turk, MP McDermott, C Eccleston, JT Farrar, ...
Pain 161 (11), 2446-2461, 2020
Economic analysis of vaccination programs: an ISPOR good practices for outcomes research task force report
J Mauskopf, B Standaert, MP Connolly, AJ Culyer, LP Garrison, ...
Value in health 21 (10), 1133-1149, 2018
Value-based pricing and reimbursement in personalised healthcare: introduction to the basic health economics
LP Garrison Jr, A Towse
Journal of personalized medicine 7 (3), 10, 2017
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR‐tyrosine kinase inhibitor therapy in non–small‐cell lung cancer
JJ Carlson, LP Garrison, SD Ramsey, DL Veenstra
Value in Health 12 (1), 20-27, 2009
Cost-effectiveness of bariatric surgical procedures for the treatment of severe obesity
BCM Wang, ES Wong, R Alfonso-Cristancho, H He, DR Flum, ...
The European Journal of Health Economics 15, 253-263, 2014
The use, safety and cost of bariatric surgery before and after Medicare's national coverage decision
DR Flum, S Kwon, K MacLeod, B Wang, R Alfonso-Cristancho, ...
Annals of surgery 254 (6), 860-865, 2011
Estimating the effect of changes in body mass index on health state preferences
Z Hakim, A Wolf, LP Garrison
Pharmacoeconomics 20, 393-404, 2002
Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers
JJ Carlson, KS Gries, K Yeung, SD Sullivan, LP Garrison
Applied health economics and health policy 12, 231-238, 2014
The system can't perform the operation now. Try again later.
Articles 1–20